Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, and non-destructive hints, so the bar is lower, but the description adds substantial behavioral context: it explains that empty sections are 'not a bug,' describes the USPTO patents API sunset and soft-fail, clarifies that FDA products only cover biologics, and details the resolution behavior for private companies. It also notes the parallel single-call execution. No contradiction with annotations exists.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loads purpose and usage guidelines, then systematically lists data sources and return fields. Every sentence provides essential information for a complex tool with many output facets and edge cases, so the length is justified. It is not overly redundant, but the frequent parenthetical asides and semicolon-separated lists make it slightly dense.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description must fully explain the return structure, and it does: it lists all top-level fields (cik, company_name, resolved_from/resolved_to, recent_filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, sources_used, sources_failed) and covers edge cases like empty sections, private companies, and soft-failing sources. It is complete for an agent to know what to expect and how to interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the schema already documents both `type` and `value` thoroughly. The description adds extra meaning by explaining that `type` accepts 'company' or 'ticker' interchangeably and that `value` can be any of ticker/CIK/name, including the resolution and private-company fallback behavior. This goes beyond the schema, earning a 4.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user queries ('Tell me about X', 'research Acme'), then states the core action: 'full cross-source profile of a US public company in ONE parallel call.' It clearly identifies the verb (profile/research), the resource (US public company), and contrasts with chaining single-pack lookups, making it easy for an agent to distinguish from siblings like deep_research or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit guidance to 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view,' which is a clear when-to-use directive with a named alternative. It also outlines accepted input shapes and the private-company fallback. However, it does not explicitly state when to use other tools (e.g., deep_research for in-depth analysis), so it lacks a when-not clause.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation3/5

There are multiple overlapping tools for querying data (ask_pipeworx, ask_pipeworx_grounded, deep_research, validate_claim, bet_research) that could confuse an agent, though descriptions are detailed enough to distinguish most. Tools like polymarket_edges and polymarket_edge_tracker are closely related, and ai_visibility_check vs scan_competitor_ai_presence overlap.

Naming Consistency2/5

Naming is highly inconsistent: some follow verb_noun (cfpb_search_complaints, resolve_entity, subscribe, recall), but many use varied patterns like adjectives (ai_visibility_check), imperative phrases (ask_pipeworx, scan_competitor_ai_presence), or compound/specialized names (polymarket_arbitrage, generate_llms_txt). No consistent prefix or convention is used across the toolset.

Tool Count2/5

With 36 tools spanning diverse domains (prediction markets, SEC filings, CFPB complaints, AI visibility, npm packages, IPC subscriptions), the server is sprawling and over-scoped. Many tools are specialized niche additions (polymarket_fill_risk, scan_dependency, generate_llms_txt) that expand the count without strong cohesion.

Completeness3/5

The toolset covers core areas well (entity resolution, profile, comparison, recent changes, search, claims verification, subscriptions). However, gaps exist: no update/delete for CFPB complaints (read-only), no direct raw SEC filing retrieval, and some lifecycle operations (e.g., editing subscriptions) are missing.